NFKB1 and Cognitive impairment: Furthermore, in a model of lipopolysaccharide (LPS)-induced brain inflammation, UA administered by oral gavage (10 or 20 mg/kg/day) significantly improved cognitive deficits, which was attributed to decreased inflammatory mediators, including COX2, iNOS, TNFα, and various NFκB-dependent inflammatory interleukins [72].